Global Glucose Monitoring Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Glucose Monitoring Devices Market Size

• The global Glucose Monitoring Devices market size was valued at USD 9.78 Billion in 2024 and is expected to reach USD 20.98 Billion by 2032, at a CAGR of 10.80 % during the forecast period
• This growth is driven by factors such as the rising global diabetic population, increasing awareness of blood glucose monitoring, and advancements in glucose meter technology

Glucose Monitoring Devices Market Analysis

• Glucose Monitoring Devices are essential diagnostic tools that enable accurate and convenient blood glucose tracking in home-based settings, supporting early detection and ongoing management of diabetes
• The demand for these devices is significantly driven by the aging population, increasing prevalence of diabetes, and rising awareness of preventive healthcare
• North America is expected to dominate the Glucose Monitoring Devices market due to the presence of a well-established healthcare infrastructure and high consumer adoption of at-home health monitoring devices
• Asia-Pacific is expected to be the fastest growing region in the Glucose Monitoring Devices market during the forecast period due to rapid urbanization, rising healthcare awareness, and supportive government health initiatives Continuous Glucose Monitoring Devices segment is expected to dominate the Glucose Monitoring Devices market with a market share of 56.38% due to increasing demand for real-time blood glucose tracking, advancements in sensor-based technologies, and rising prevalence of diabetes requiring continuous monitoring for effective management.

Report Scope and Glucose Monitoring Devices Market Segmentation

Glucose Monitoring Devices Market Trends

“Integration of Digital Health Technologies”

• Increasing adoption of smartphone-compatible Glucose Monitoring Devices and mobile apps enhances patient engagement and self-monitoring.
• Advancements in cloud-based data platforms enable real-time glucose tracking and sharing with healthcare providers.

For Instance

• The increasing use of smartphone-compatible glucose monitoring devices and mobile apps is boosting patient engagement and self-monitoring. Cloud-based platforms allow real-time data sharing with healthcare providers, while AI-driven analytics deliver predictive insights, enabling more effective glycemic control and personalized diabetes management, significantly enhancing outcomes for diabetic patients.
• AI and analytics integration provide predictive insights for better glycemic control and personalized diabetes management.

Glucose Monitoring Devices Market Dynamics

Driver

Increase the cases  of  Diabetes

• The increasing number of individuals diagnosed with diabetes creates a substantial demand for effective insulin therapies, which in turn drives growth in the  global insulin market.
• Factors such as sedentary lifestyles, unhealthy diets, and an aging population contribute to this trend, resulting in a larger patient base requiring diabetes management solutions.

For instance,   

• In 2024, as per WHO  , the number of people living with diabetes rose from 200 million in 1990 to 830 million in 2022. This rise was more rapid in low- and middle-income countries than in high-income countries. Diabetes caused over 2 million deaths in 2021, with significant complications like kidney failure and heart disease.
• The heightened need for insulin products spurs innovation and competition among pharmaceutical companies, leading to the development of new formulations and delivery methods.
• This dynamic environment supports existing therapies and encourages the introduction of affordable biosimilars and improved technologies, further expanding market opportunities.

Opportunity

“Expansion in Emerging Markets”

• Rising prevalence of diabetes in Asia-Pacific, Latin America, and Africa is creating strong demand for affordable glucose monitoring devices.
• Government-led health awareness campaigns and subsidized healthcare programs are boosting product adoption.

For Instance,

• The rising diabetes prevalence in Asia-Pacific, Latin America, and Africa is driving demand for affordable glucose monitoring devices. Government health campaigns and subsidized programs support adoption, while increased investments in localized manufacturing and distribution by key players are enhancing accessibility, affordability, and market penetration in these emerging regions.
• Growing investments by key players in localized manufacturing and distribution are improving accessibility and affordability.

Restraint/Challenge

“Accuracy and Consistency of Readings”

• Differences in calibration methods and sensor technologies across various Glucose Monitoring Devices can result in inconsistent readings, making it difficult to ensure reliable monitoring and comparison over time.
• Inaccurate results can stem from improper usage, such as insufficient blood sample, incorrect strip handling, or failure to clean the device, especially in home settings where professional guidance is limited.

For Instance

• Variations in calibration and sensor technologies can lead to inconsistent glucose readings, complicating long-term monitoring. Inaccuracies often arise from improper usage or environmental factors like temperature and humidity. This is especially problematic in home settings with limited professional oversight, affecting the reliability of low-cost or older monitoring devices.
• External factors like temperature, humidity, and altitude can impact the accuracy of readings, particularly in low-cost or older devices not designed to compensate for environmental fluctuations.

Glucose Monitoring Devices Market Scope

The market is segmented on the basis Product, Type, Testing Site, Technique, Distribution Channel, End-User.

In 2025, the Self-Monitoring Blood Glucose System is projected to dominate the market with a largest share in application segment

The Self-Monitoring Blood Glucose System segment is expected to dominate the Glucose Monitoring Devices market with the largest share of 55.30% in 2024 due to increasing demand for accurate, user-friendly glucose monitoring solutions at home. As a cornerstone of diabetes management, advancements in device accuracy, portability, and digital connectivity enhance patient engagement and glycemic control. The growing diabetic population, rising health awareness, and the shift toward self-care practices further contribute to the segment’s market dominance.

The Continuous Glucose Monitoring System is expected to account for the largest share during the forecast period in technology market

In 2025, the Continuous Glucose Monitoring System segment is expected to dominate the Glucose Monitoring Devices market with the largest market share of 57.89% due to their convenience, real-time tracking capabilities, and ability to provide comprehensive glucose trend data. As a vital component of diabetes care, advancements in sensor accuracy, wearable integration, and data connectivity enhance patient engagement and long-term glycemic control. The increasing prevalence of diabetes and growing demand for proactive, technology-driven health management solutions further contribute to the segment’s market dominance.

Glucose Monitoring Devices Market Regional Analysis

“North America Holds the Largest Share in the Glucose Monitoring Devices Market”

• North America dominates the Glucose Monitoring Devices market, driven by advanced healthcare infrastructure, high adoption of digital health solutions, and strong presence of key market players
• The U.S. holds a significant share due to increased demand for remote patient monitoring, rising prevalence of diabetes, and growing preference for home-based glucose tracking
• The availability of well-established reimbursement policies and growing investments in healthcare IT by leading technology firms further strengthen the market
• In addition, the increasing shift toward value-based care, integration of AI and connected health platforms, and the rising elderly population are fueling market expansion across the region

“Asia-Pacific is Projected to Register the Highest CAGR in the Glucose Monitoring Devices Market”

• The Asia-Pacific region is expected to witness the highest growth rate in the Glucose Monitoring Devices market, driven by rapid expansion in healthcare infrastructure, increasing digital health awareness, and rising demand for home-based medical services
• Countries such as China, India, and Japan are emerging as key markets due to their growing aging populations, which are more prone to chronic illnesses requiring continuous care and monitoring
• Japan, with its advanced healthcare technology and strong focus on innovation, remains a crucial market for Glucose Monitoring Devices. The country continues to lead in the adoption of AI-powered and integrated health platforms to support elderly care
• China and India, with their large populations and increasing burden of chronic diseases, are witnessing growing government and private sector investments in telehealth, remote monitoring, and digital healthcare solutions. The expanding footprint of global health tech companies and improving access to home healthcare services further fuel market growth

Glucose Monitoring Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• F. Hoffmann-La Roche Ltd (Switzerland)
• Dexcom, Inc. (U.S)
• B. Braun Melsungen AG (Germany)
• Medtronic (Ireland)
• Lifespan Health System (U.S)
• Ascensia Diabetes Care Holdings AG (Switzerland)
• Terumo Europe NV (Belgium)
• Abbott (U.S)
• Sanofi (Germany)
• DiaMonTech AG (Germany)
• ACON Laboratories, Inc. (U.S)
• AgaMatrix (U.S)
• ARKRAY, Inc. (Japan)
• BD (U.S)
• Bionime Corporation (Taiwan)
• Johnson & Johnson Private Limited (U.S)

Latest Developments in Global Glucose Monitoring Devices Market

• In 2022, LiveMetric launched LiveOne, a nano-sensor technology used to monitor blood pressure every 10 seconds. LiveOne is a wrist-worn, cuff-free solution that gives real-time measurements for better management of people suffering from hypertension and other cardiovascular disorders.
• In 2022, InBody launched the InBody BP 170 blood pressure monitor, a new at-home automatic blood pressure monitor with a large display for optimal visibility.

SKU-1428